Interestingly, we identified that patients with high CHK1/WEE1 co-expression are associated with a significant enrichment in genes involved in metabolism, ABC transporters, aggrephagy, EGFR signaling pathway and upregulated in CD1 and CD2 MM molecular subgroups. The gene discussed is ABCG2; the disease is Miyoshi myopathy.